MedTrace Logo

Hepatitis C Screening Alerts

NCT05710120 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125706

Last updated 2024-02-16

No results posted yet for this study

Summary

The objective of this study is to evaluate whether alerts that identify patients without hepatitis C infection to healthcare providers and clinic staff can increase the uptake of screening for hepatitis C. A period of time without alerts will be compared to a period of time with alerts.

Conditions

  • Hepatitis C

Interventions

OTHER

Hepatitis C Screening Alerts in CHORUS™

ZS Associates developed a machine learning-based model that provides a numeric % chance of returning a positive hepatitis C test for a patient without diagnosed hepatitis C infection. The data used to develop the model included a US-based large scale data source including electronic medical records, medical claims, and pharmacy claims as well as social determinants of health identified from open-source data. Clinical Health Outcomes Reporting \& Utilization Service (CHORUS™) is a web-based reporting solution that transforms electronic health record data into meaningful information for healthcare providers. CHORUS™ generates a weekly email report that alerts clinics to patients who have a scheduled appt in the coming week and may require attention. In the after period of this study, the alert will identify patients who are eligible to be screened for hepatitis C infection and provide the % chance of returning a positive hepatitis C infection test.

OTHER

Standard of Care

CHORUS™ is a service provided to participating clinics and has been used by AIDS Healthcare Foundation for normal healthcare operations for quality improvement and retention in care in recent years. NO alerts identifying patients who are eligible to be screening for hepatitis C infection will be disseminated.

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • ZS

    collaborator INDUSTRY

  • AIDS Healthcare Foundation

    collaborator OTHER

  • Epividian

    lead INDUSTRY

Principal Investigators

  • Douglas Dieterich, MD · Mount Sinai Healthcare System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-16
Primary Completion
2023-10-17
Completion
2023-10-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05710120 on ClinicalTrials.gov